Corbus Pharmaceuticals Holdings (CRBP) Short term Debt (2021 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Short term Debt of $12.8 million for Q1 2024, up 154.85% year-over-year from $5.0 million in Q2 2023, and down 19.76% quarter-over-quarter from $15.9 million in Q4 2023.
Corbus Pharmaceuticals Holdings (CRBP) Short term Debt (2021 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Short term Debt history runs 4 years deep, the most recent figure standing at $12.8 million for Q1 2024.
- In Q1 2024, Short term Debt rose 154.85% year-over-year to $12.8 million; the TTM figure through Mar 2024 stood at $12.8 million (up 154.85% YoY), while the FY2023 annual figure was $15.9 million, up 469.03% from the prior year.
- Short term Debt for Q1 2024 stood at $12.8 million, down from $15.9 million in the prior quarter.
- The five-year high for Short term Debt was $17.8 million in Q3 2023, with the low at $2.8 million in Q4 2022.
- The 4-year median for Short term Debt is $7.2 million (2022), against an average of $8.7 million.
- The sharpest annual moves came in 2022 and 2023: Short term Debt dropped 9.62% in 2022, then surged 469.03% in 2023.
- Corbus Pharmaceuticals Holdings' Short term Debt stood at $3.1 million in 2021, then retreated by 9.62% to $2.8 million in 2022, then soared by 469.03% to $15.9 million in 2023, then retreated by 19.76% to $12.8 million in 2024.
- Business Quant data shows CRBP's Short term Debt at $12.8 million in Q1 2024, $15.9 million in Q4 2023, and $17.8 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 12.76 Mn |
| Dec 31, 2023 | 15.91 Mn |
| Sep 30, 2023 | 17.85 Mn |
| Jun 30, 2023 | 7.02 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 9.88 Mn |
| Jun 30, 2022 | 7.47 Mn |
| Mar 31, 2022 | 5.18 Mn |
| Dec 31, 2021 | 3.09 Mn |